Tag: Reuters

Posted on

UPDATE 1-FDA panel backs approval of GSK asthma drug in adults – Reuters


MedPage Today

UPDATE 1-FDA panel backs approval of GSK asthma drug in adults
Reuters
If approved, the drug would be marketed under the trade name Nucala and be the first new biologic treatment for severe asthma in more than a decade. Asthma affects more than 22 million people in the United States. Severe asthma accounts for 5 to 10 …
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in …StreetInsider.com
Asthma Drug Targeting IL-5 Wins Partial Backing From FDA AdvisersMedPage Today
FDA committee recommends approval of Nucala for adults with severe asthmaHealio
Reuters India
all 12 news articles »

View full post on asthma – Google News

Posted on

FDA panel backs approval of GSK asthma drug in adults – Reuters


Reuters

FDA panel backs approval of GSK asthma drug in adults
Reuters
An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older. The panel voted 10 to 4 against approving it in children aged …
UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in …StreetInsider.com
FDA committee recommends approval of Nucala for adults with severe asthmaHealio

all 8 news articles »

View full post on asthma – Google News

Posted on

Cesarean birth may raise baby’s risk of asthma, diabetes and obesity – Reuters


Channel News Asia

Cesarean birth may raise baby's risk of asthma, diabetes and obesity
Reuters
(Reuters Health) – Cesarean section may leave babies vulnerable to chronic health problems such as asthma, diabetes and obesity, a new analysis hints. Much of the research included in the study cannot prove that C-section delivery causes medical issues …
Babies born by C-section may be more likely to be obese, have asthma or …Mirror.co.uk
New study explores whether newborns delivered by c-section face higher risk of …Medical Xpress

all 9 news articles »

View full post on asthma – Google News

Posted on

Inhaler ban boosts costs for people with asthma – Reuters


Channel News Asia

Inhaler ban boosts costs for people with asthma
Reuters
(Reuters Health) – A 2008 ban on chlorofluorocarbons (CFCs) has ended up being particularly costly for people with asthma. The ban changed the type of albuterol inhaler available in the U.S., and since then costs have gone up and inhaler use has gone …
Environmental Concerns Led to Jump in Cost of Asthma Inhalers: StudyU.S. News & World Report

all 4 news articles »

View full post on asthma – Google News

Posted on

US FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Reuters


Reuters

US FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Reuters
(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger …
GlaxoSmithKline plc (ADR) Gets FDA Approval For Breo Ellipta To Treat Asthma …Bidness ETC
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
WRAL Tech Wire
all 65 news articles »

View full post on asthma – Google News

Posted on

FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug – Reuters


Reuters

FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Reuters
(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger …
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the USMarketWatch
FDA Okays Breo Ellipta for Asthma in AdultsMedscape
StreetInsider.com –CNNMoney –HCPLive
all 23 news articles »

View full post on asthma – Google News